Global Veterinary CRO Market Size By Type (Clinical Trials, Toxicology), By Application (Dogs, Cats), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary Contract Research Organization (CRO) Market was valued at USD 1.1 billion in 2023 and is expected to reach USD 2.4 billion by 2031, growing at a CAGR of 10.2% from 2023 to 2031. The growth of this market is propelled by rising demand for animal health solutions, increased R&D activities in veterinary pharmaceuticals, and the growing outsourcing trend by animal health companies to reduce time-to-market and operational costs. Veterinary CROs offer a range of services such as regulatory support, preclinical and clinical trials, pharmacovigilance, and market access services, making them indispensable in the animal healthcare ecosystem.

Drivers:

1. Surge in R&D Investments in Veterinary Pharmaceuticals:

Growing focus on innovative therapies for companion and livestock animals is fueling R&D expenditures by animal health companies. This, in turn, is boosting demand for specialized CROs with veterinary research expertise.

2. Increasing Pet Ownership and Companion Animal Healthcare Spending:

Rising global pet adoption and heightened awareness about pet health are encouraging pharmaceutical firms to develop more targeted and effective treatments, driving the need for external research partners.

3. Cost Efficiency and Expertise in Outsourcing:

Animal health companies are increasingly outsourcing R&D to CROs to leverage their specialized knowledge and reduce the cost and duration of product development cycles.

Restraints:

1. Regulatory Complexity and Delays:

Veterinary CROs often face varied and stringent regulatory requirements across different geographies, leading to potential delays and increased operational complexity.

2. Limited Skilled Professionals:

The availability of veterinarians and researchers with specific expertise in regulatory science and clinical research is limited, which may affect the ability of CROs to scale up operations.

Opportunity:

1. Growing Livestock Population in Emerging Economies:

Rising meat and dairy consumption is boosting livestock farming in countries like India, China, and Brazil, presenting immense growth potential for veterinary CRO services.

2. Technological Integration in Veterinary Research:

The integration of AI, digital monitoring devices, and big data analytics into animal research offers CROs new avenues to enhance trial accuracy, improve data collection, and drive innovation.

Market by System Type Insights:

Based on system type, the Clinical Trials Services segment held the largest share in 2023. These services are critical for assessing the safety and efficacy of veterinary drugs and vaccines. Due to growing complexity in trial design and regulatory approval pathways, sponsors are increasingly turning to CROs to manage these studies effectively.

Market by End-use Insights:

The Pharmaceutical & Biotechnology Companies segment dominated the end-use category in 2023, owing to the extensive outsourcing of drug development tasks to CROs. This segment continues to lead as companies strive to streamline development pipelines and focus internal resources on core capabilities.

Market by Regional Insights:

North America led the global veterinary CRO market in 2023, driven by the presence of leading animal health companies, strong veterinary infrastructure, and a high prevalence of companion animals. Asia-Pacific is expected to grow at the fastest rate during the forecast period due to expanding livestock sectors, increasing investments in animal healthcare, and cost-effective CRO service offerings.

Competitive Scenario:

Key players in the global veterinary CRO market include Charles River Laboratories, Clinvet, Triveritas, Orbis Animal Health, VETSPIN SRL, Oncovet Clinical Research, Inotiv, and KLIFOVET AG. These companies are strengthening their position through acquisitions, partnerships, and service portfolio expansions.

Key Developments:

In 2023, Charles River Laboratories expanded its veterinary capabilities with a new research facility in the U.S. focused on livestock trials.

In 2024, Clinvet partnered with a major pharmaceutical firm to conduct multi-species clinical studies across Asia-Pacific.

In 2025, Oncovet Clinical Research launched a proprietary AI-based system to enhance data quality and accelerate veterinary trial timelines.

Scope of Work – Global Veterinary CRO Market

Report Metric Details

Market Size (2023) USD 1.1 Billion

Projected Market Size (2031) USD 2.4 Billion

CAGR (2023–2031) 10.2%

Market Segments System Type (Clinical Trials, Regulatory Affairs, etc.), End-use (Pharmaceutical Companies, Academic Institutes)

Growth Drivers Rising R&D Investments, Outsourcing Trend, Pet Health Awareness

Opportunities Technological Innovation, Emerging Market Ex